Terms ending in 2041
Every in-force patent on Seegene, Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,781,180 | Detection of Abnormal Signal Using Two or More Datasets In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 11,915,796 | Method For Calibrating A Data Set Of A Target Analyte Using A Normalization Coefficient In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 11,837,326 | Methods for Preparing Oligonucleotides for Detecting Target Nucleic Acid Sequences with a Maximum Coverage In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 12,217,869 | Image Diagnosis Apparatus Using Deep Learning Model and Method Therefor In force · High confidence | Korea Advanced Institute of Science and Technology and Seegene Medical Foundation | In force | High confidence | |
| US 11,961,590 | Methods for Preparing Optimal Combination of Oligonucleotides In force · High confidence | Seegene, Inc. | In force | High confidence | |
| US 12,546,720 | Optical Signal Detection Device Comprising Sample Holder Divided into Sample Areas and Light Source Units Dedicated Thereto In force · High confidence | Seegene, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.